ELAN — Elanco Animal Health Balance Sheet
0.000.00%
- $4.70bn
- $8.55bn
- $4.44bn
- 64
- 70
- 54
- 67
Annual balance sheet for Elanco Animal Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 495 | 638 | 345 | 352 | 468 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,077 | 1,028 | 1,002 | 1,010 | 886 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 3,417 | 3,276 | 3,279 | 3,407 | 3,215 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,503 | 1,222 | 1,140 | 1,166 | 1,115 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 17,693 | 16,483 | 15,491 | 14,362 | 12,614 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2,076 | 1,643 | 1,702 | 1,241 | 1,315 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 9,217 | 8,945 | 8,202 | 8,139 | 6,518 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 8,476 | 7,538 | 7,289 | 6,223 | 6,096 |
Total Liabilities & Shareholders' Equity | 17,693 | 16,483 | 15,491 | 14,362 | 12,614 |
Total Common Shares Outstanding |